| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2016 | SCYX Scynexis Inc | Francois Eric | Chief Financial Officer | Buy | 15,000 | $2.39 | $35,850.00 | New | |
| Jun 24, 2016 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 100,000 | $2.39 | $239,000.00 | +80.0% | |
| Jun 15, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Zhou Rong59 | EVP, Production Center | Sell | 1,551 | $15.85 | $24,583.82 | -4.0% | |
| Jun 14, 2016 | SNY Sanofi | Sanofi | 10% Owner | Buy | 64,731 | $363.86 | $23,552,858.70 | - | |
| Jun 13, 2016 | BHC Bausch Health Companies Inc. | Ross Thomas W. Sr. | Director | Buy | 4,000 | $24.40 | $97,600.00 | +22.4% | |
| Jun 13, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 7,500 | $15.94 | $119,535.75 | -20.5% | |
| Jun 10, 2016 | LLY Eli Lilly & Co | Barnes Melissa S | Chief Eth/ Cmpl Ofcr &SVP, Erm | Sell | 992 | $73.77 | $73,179.84 | -8.5% | |
| Jun 10, 2016 | BHC Bausch Health Companies Inc. | Papa Joseph C | Chairman &CEO | Buy | 202,000 | $24.48 | $4,944,960.00 | +9.0% | |
| Jun 9, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Shandell Jason B. | President | Sell | 9,904 | $16.43 | $162,722.72 | -4.4% | |
| Jun 8, 2016 | PBH Prestige Consumer Healthcare Inc. | Byom John E | Director | Sell | 1,249 | $53.35 | $66,634.15 | -4.5% | |
| Jun 8, 2016 | PBH Prestige Consumer Healthcare Inc. | Parkinson John | Senior Vp- International | Sell | 25,143 | $53.57 | $1,346,910.51 | -28.1% | |
| Jun 7, 2016 | JNJ Johnson & Johnson | Pruden Gary J | Exec VP, Ww Chair, Med Devices | Sell | 9,735 | $116.03 | $1,129,552.05 | -18.2% | |
| Jun 7, 2016 | JNJ Johnson & Johnson | Kapusta Ronald A | Controller, CAO | Sell | 3,000 | $115.79 | $347,381.10 | -10.4% | |
| Jun 7, 2016 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 938 | $47.66 | $44,706.01 | -5.2% | |
| Jun 6, 2016 | PCRX Pacira Biosciences, Inc. | Kronenfeld Mark A. | Director | Sell | 900 | $46.95 | $42,255.00 | -23.4% | |
| Jun 6, 2016 | PCRX Pacira Biosciences, Inc. | Hastings Paul J75 | Director | Sell | 1,136 | $46.95 | $53,335.20 | -39.8% | |
| Jun 6, 2016 | PCRX Pacira Biosciences, Inc. | Brege Laura62 | Director | Sell | 1,000 | $46.95 | $46,950.00 | -50.0% | |
| Jun 6, 2016 | EBS Emergent Biosolutions Inc. | Joulwan George A | Director | Sell | 4,700 | $44.12 | $207,364.00 | -18.4% | |
| Jun 6, 2016 | PCRX Pacira Biosciences, Inc. | Williams Kristen Marie76 | CAO And General Counsel | Sell | 600 | $47.20 | $28,319.40 | -8.0% | |
| Jun 3, 2016 | IRWD Ironwood Pharmaceuticals Inc | Olanoff Lawrence S | Director | Sell | 2,200 | $12.92 | $28,424.00 | -6.3% | |
| Jun 2, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, SVP &Treasurer | Sell | 2,297 | $16.00 | $36,752.00 | -3.3% | |
| Jun 1, 2016 | EBS Emergent Biosolutions Inc. | Abdun-Nabi Daniel | President &CEO | Sell | 8,699 | $43.74 | $380,494.26 | -4.8% | |
| May 31, 2016 | PBH Prestige Consumer Healthcare Inc. | Boyko Jean A | SVP, Science And Technology | Sell | 3,500 | $53.78 | $188,230.00 | -21.5% | |
| May 31, 2016 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 200,000 | $75.12 | $15,023,200.00 | -0.2% | |
| May 27, 2016 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 9,835 | $43.50 | $427,822.50 | -0.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.